Oracle (NYSE:ORCL) Price Target Raised to $360.00 at UBS Group

Key Points

• UBS Group has raised its price target for Oracle (NYSE:ORCL) from $280.00 to $360.00, indicating a potential upside of 6.62% from the current price, while maintaining a "buy" rating on the stock.
• The stock price of Oracle has surged 39.8%, reaching $337.65, with trading volume significantly exceeding the average.
• Insiders from Oracle sold over 444,000 shares collectively this past quarter, with notable transactions by Director Naomi O. Seligman and Vice Chairman Jeffrey Henley.

Oracle (NYSE:ORCL - Get Free Report) had its target price increased by investment analysts at UBS Group from $280.00 to $360.00 in a report issued on Wednesday, Marketbeat reports. The brokerage currently has a "buy" rating on the enterprise software provider's stock. UBS Group's price objective points to a potential upside of 23.26% from the stock's current price.

A number of other research firms have also commented on ORCL. Bank of America raised shares of Oracle from a "neutral" rating to a "buy" rating and upped their price objective for the company from $295.00 to $368.00 in a research note on Wednesday. Oppenheimer reiterated an "outperform" rating on shares of Oracle in a research report on Wednesday, June 18th. KeyCorp boosted their target price on shares of Oracle from $200.00 to $225.00 and gave the company an "overweight" rating in a research report on Thursday, June 12th. Mizuho boosted their target price on shares of Oracle from $300.00 to $350.00 and gave the company an "outperform" rating in a research report on Wednesday. Finally, Piper Sandler boosted their target price on shares of Oracle from $270.00 to $330.00 and gave the company an "overweight" rating in a research report on Wednesday. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $296.84.

Oracle Trading Down 5.1%

Shares of NYSE:ORCL traded down $15.79 during trading on Wednesday, reaching $292.07. The stock had a trading volume of 51,618,969 shares, compared to its average volume of 20,941,788. The firm's fifty day moving average is $244.69 and its 200 day moving average is $190.37. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.75 and a current ratio of 0.62. Oracle has a 52 week low of $118.86 and a 52 week high of $345.72. The stock has a market cap of $820.38 billion, a price-to-earnings ratio of 67.61, a P/E/G ratio of 4.10 and a beta of 1.46.

Oracle (NYSE:ORCL - Get Free Report) last posted its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.06. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The company had revenue of $15.90 billion for the quarter, compared to analyst estimates of $15.58 billion. During the same period in the prior year, the firm posted $1.63 EPS. The company's quarterly revenue was up 11.3% on a year-over-year basis. As a group, equities analysts forecast that Oracle will post 5 EPS for the current fiscal year.

Insider Activity

In other Oracle news, insider Clayton M. Magouyrk sold 15,000 shares of the company's stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $214.10, for a total transaction of $3,211,500.00. Following the transaction, the insider owned 60,722 shares in the company, valued at approximately $13,000,580.20. This represents a 19.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Naomi O. Seligman sold 3,303 shares of the stock in a transaction dated Wednesday, July 16th. The shares were sold at an average price of $233.32, for a total transaction of $770,655.96. Following the completion of the sale, the director owned 31,447 shares of the company's stock, valued at approximately $7,337,214.04. This represents a 9.51% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 44,183 shares of company stock valued at $10,353,198. 42.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Oracle

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Valeo Financial Advisors LLC boosted its position in Oracle by 5.0% during the second quarter. Valeo Financial Advisors LLC now owns 95,299 shares of the enterprise software provider's stock worth $20,835,000 after purchasing an additional 4,512 shares during the period. Milestones Private Investment Advisors LLC purchased a new stake in shares of Oracle in the second quarter worth about $744,000. Silicon Valley Capital Partners lifted its holdings in shares of Oracle by 7.1% in the second quarter. Silicon Valley Capital Partners now owns 74,129 shares of the enterprise software provider's stock worth $16,207,000 after buying an additional 4,912 shares in the last quarter. WT Wealth Management purchased a new stake in shares of Oracle in the second quarter worth about $262,000. Finally, NWF Advisory Services Inc. lifted its holdings in shares of Oracle by 6.3% in the second quarter. NWF Advisory Services Inc. now owns 2,596 shares of the enterprise software provider's stock worth $568,000 after buying an additional 153 shares in the last quarter. Institutional investors own 42.44% of the company's stock.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.